News | November 16, 2021
Pre-diabetes is a much more serious issue in India: Fitterfly
Two out of three people under the age of 40 are at risk of prediabetes
Two out of three people under the age of 40 are at risk of prediabetes
Forty-two per cent Indian patients with Coronary Artery Disease (CAD) or Peripheral Artery Disease (PAD) described “confusion about what I was supposed to do next” as an important barrier to early and accurate diagnosis
Diabetes has the highest prevalence and comorbidities among all NCD’s in India and it is mostly found among people in the south and east India
The initiative will engage adolescents and youth of India in decisions about their reproductive health
The 50-bed hospital is positioned to address complexities specific to women and children, going beyond a birthing facility
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
The Drug Controller General of India (DCGI), is reviewing clinical data of molnupiravir for the treatment of Covid-19 in adults in India
The company will provide the technical and financial resources to support the study
Evidence also shows better immune response to virus among users of spray
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Subscribe To Our Newsletter & Stay Updated
